Johnson & Johnson (JNJ) R&D In Process (2010 - 2023)

Johnson & Johnson's R&D In Process history runs 13 years deep, the most recent figure standing at $49.0 million for Q2 2023.

• In Q2 2023, R&D In Process fell 91.97% year-over-year to $49.0 million; the TTM figure through Apr 2023 stood at $222.0 million (down 85.3% YoY), while the FY2023 annual figure was $783.0 million, down 13.0% from the prior year.
• R&D In Process came in at $49.0 million for Q2 2023 at Johnson & Johnson, down from $173.0 million in the prior quarter.
• In the past five years, R&D In Process ranged from a high of $900.0 million in Q4 2021 to a low of $6.0 million in Q2 2020.
• A 5-year average of $350.4 million and a median of $155.5 million in 2020 frame the typical range for R&D In Process.
• Across the five-year window, R&D In Process jumped 552.17% in 2021 and slumped 91.97% in 2023, its largest moves.
• Johnson & Johnson's R&D In Process stood at $890.0 million in 2019, then tumbled by 84.49% to $138.0 million in 2020, then surged by 552.17% to $900.0 million in 2021, then plunged by 32.22% to $610.0 million in 2022, then plunged by 91.97% to $49.0 million in 2023.
• According to Business Quant data, R&D In Process over the past three periods registered $49.0 million, $173.0 million, and $610.0 million for Q2 2023, Q1 2023, and Q2 2022 respectively.

Peer Comparison